Neurocognitive improvement in HIV-positive patients treated with dolutegravir-based regimens

Neurocognitive improvement in HIV-positive patients treated with dolutegravir-based regimens

Background: Neurocognitive disorders due to human immunodeficiency virus (HIV) remain highly prevalent, specifically mild forms despite effective antiretroviral therapy (ART). Dolutegravir-based regimens are the first line of treatment for adult HIV-positive patients. Controversies exist regarding t...

Full description

Bibliographic Details
Main Authors: Janine Rodrigues, Karishma Lowton
Format: Article
Language:English
Published: AOSIS 2023-09-01
Series:South African Journal of Psychiatry
Subjects:
hiv-associated neurocognitive disorders
bnce
ihds
dolutegravir
neurocognitive screening
neurocognitive impairment
south africa.
Online Access:https://sajp.org.za/index.php/sajp/article/view/2071

Internet

https://sajp.org.za/index.php/sajp/article/view/2071

Similar Items